Subjects
The BREAST trial is an ongoing multicenter randomized controlled trial comparing AFT (intervention group) with IBR (control group), running from November 2015 to approximately October 2025, with the last reconstruction surgery performed in October 2020. The primary outcome for this study is the QoL, measured 12 months after the final reconstruction surgery. Moreover, the efficacy and safety of these reconstruction methods are studied [To be eligible for participation in this aesthetic outcome study of the BREAST trial, patients had to meet the inclusion and exclusion criteria of the BREAST trial and be at least 12 months after their final reconstruction surgery (Table Inclusion and exclusion criteria for the BREAST trial